BARKER DAVID L 4
4 · Bionano Genomics, Inc. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Bionano (BNGO) Director David Barker Receives Award of 9,149 Shares
What Happened
David L. Barker, a director of Bionano Genomics (BNGO), received a grant/award of 9,149 shares on 2026-05-14. The award price is $0.00 (no cash paid); total immediate value reported is $0 on the Form 4 because these are restricted/derivative shares subject to vesting rather than an open-market purchase.
Key Details
- Transaction date: 2026-05-14; Transaction type/code: Award/Grant (A) — derivative security.
- Shares granted: 9,149; acquisition price: $0.00; reported value at grant: $0.
- Shares owned after transaction: not specified in the provided filing.
- Vesting/conditions (Footnote F1): Shares vest in equal monthly installments over 12 months, will be fully vested by the company’s next annual meeting if service continues, and vest in full upon a Change of Control. Vesting is subject to the plan’s Continuous Service requirement.
- Filing timeliness: Report filed with Form 4 dated 2026-05-14 (same date as transaction), indicating a timely filing.
Context
This is a compensation-related award typical for directors to align incentives and encourage retention; it is not an outright purchase (which some investors consider a stronger bullish signal). Because the shares vest over time and may forfeit if service ends, the grant primarily reflects company compensation practice rather than immediate insider buying or selling.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-05-14+9,149→ 9,149 totalExercise: $1.19Exp: 2036-05-13→ Common Stock (9,149 underlying)
Footnotes (1)
- [F1]The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan).